AP

Aclairo Pharmaceutical Development Group at SOT 2027

Mar 14–17, 2027 San Antonio, TX ~4k attendees Website

Aclairo Pharmaceutical Development Group takes part in 2 sessions at SOT 2027 in San Antonio. Its people speak on the regulatory view of minipigs for developmental, reproductive and juvenile toxicity studies, and on safety testing of gene editors delivered in lipid nanoparticles. The Virginia consultancy advises drug developers on nonclinical safety, toxicology and regulatory strategy.

OrganizationSOT 2027 Attendance
AP
Aclairo Pharmaceutical Development Group
Vienna, VA
Consultancies
Drug development consultancy advising on nonclinical safety, toxicology and regulatory strategy.
Talk
Wed, Mar 17
11:45am–12:00pm
Regulatory Perspective on the Use of the Minipig as an Alternative Species for DART and Juvenile Toxicity Studies
Stars at Night Ballroom B2, Convention Center
Reproductive and Developmental Toxicology · Comparative Toxicology, Pathology, and Veterinary
Talk
Wed, Mar 17
3:05pm–3:25pm
Nonclinical Safety Assessment of LNP-Delivered Gene Editors
Stars at Night Ballroom B2, Convention Center
Biotechnology · Nanoscience and Advanced Materials

Explore the full SOT 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SOT 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Aclairo Pharmaceutical Development Group

Tell us what you sell and we’ll find the people at Aclairo Pharmaceutical Development Group most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Society of Toxicology. Organization details are derived from SOT’s published ToxExpo exhibitor list, its online program planner and each exhibitor’s own profile and website. Submit a correction